289 related articles for article (PubMed ID: 15515432)
1. Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein.
Nagasawa H; Sasaki H; Uto Y; Kubo S; Hori H
Anticancer Res; 2004; 24(5C):3361-6. PubMed ID: 15515432
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.
Mohamad SB; Nagasawa H; Uto Y; Hori H
Anticancer Res; 2002; 22(6C):4297-300. PubMed ID: 12553073
[TBL] [Abstract][Full Text] [Related]
3. Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity.
Mohamad SB; Nagasawa H; Sasaki H; Uto Y; Nakagawa Y; Kawashima K; Hori H
Anticancer Res; 2003; 23(6a):4451-7. PubMed ID: 14666733
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
5. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
Yamamoto N; Naraparaju VR; Asbell SO
Cancer Res; 1996 Jun; 56(12):2827-31. PubMed ID: 8665521
[TBL] [Abstract][Full Text] [Related]
6. Subtypes of the Gc gene (vitamin D binding protein) in the Polish population.
Leśko D; Schlesinger D; Hałasa J; Mańczak M
Arch Immunol Ther Exp (Warsz); 1988; 36(6):687-93. PubMed ID: 3254118
[TBL] [Abstract][Full Text] [Related]
7. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity.
Nagasawa H; Uto Y; Sasaki H; Okamura N; Murakami A; Kubo S; Kirk KL; Hori H
Anticancer Res; 2005; 25(6A):3689-95. PubMed ID: 16302727
[TBL] [Abstract][Full Text] [Related]
8. β-Galactosidase treatment is a common first-stage modification of the three major subtypes of Gc protein to GcMAF.
Uto Y; Yamamoto S; Mukai H; Ishiyama N; Takeuchi R; Nakagawa Y; Hirota K; Terada H; Onizuka S; Hori H
Anticancer Res; 2012 Jun; 32(6):2359-64. PubMed ID: 22641675
[TBL] [Abstract][Full Text] [Related]
9. Effect of the Gc-derived macrophage-activating factor precursor (preGcMAF) on phagocytic activation of mouse peritoneal macrophages.
Uto Y; Yamamoto S; Takeuchi R; Nakagawa Y; Hirota K; Terada H; Onizuka S; Nakata E; Hori H
Anticancer Res; 2011 Jul; 31(7):2489-92. PubMed ID: 21873164
[TBL] [Abstract][Full Text] [Related]
10. Female premenopausal fracture risk is associated with gc phenotype.
Lauridsen AL; Vestergaard P; Hermann AP; Moller HJ; Mosekilde L; Nexo E
J Bone Miner Res; 2004 Jun; 19(6):875-81. PubMed ID: 15125786
[TBL] [Abstract][Full Text] [Related]
11. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
Yamamoto N; Kumashiro R
J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
[TBL] [Abstract][Full Text] [Related]
12. Identification of group specific component/vitamin D-binding protein (GC/DBP) mutants by isoelectric focusing in immobilized pH gradients.
Constans J; Cleve H
Electrophoresis; 1988 Sep; 9(9):599-602. PubMed ID: 3243257
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the vitamin D-binding protein (group-specific component) and its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusing.
Braun A; Brandhofer A; Cleve H
Electrophoresis; 1990 Jun; 11(6):478-83. PubMed ID: 2394211
[TBL] [Abstract][Full Text] [Related]
14. Protein subtype polymorphisms (Gc and Tf) in a Catalan population from Gerona (northeastern Spain).
Moreno P; Moral P
Anthropol Anz; 1988 Sep; 46(3):201-5. PubMed ID: 3190172
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).
Yamamoto N; Suyama H; Yamamoto N; Ushijima N
Int J Cancer; 2008 Jan; 122(2):461-7. PubMed ID: 17935130
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
Yamamoto N; Naraparaju VR
Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphism of group specific component (Gc) in nine Han subpopulations in China].
Xu J; Tan Q; Du R
Yi Chuan Xue Bao; 1997; 24(6):483-91. PubMed ID: 9575657
[TBL] [Abstract][Full Text] [Related]
18. The glycosylation and characterization of the candidate Gc macrophage activating factor.
Ravnsborg T; Olsen DT; Thysen AH; Christiansen M; Houen G; Højrup P
Biochim Biophys Acta; 2010 Apr; 1804(4):909-17. PubMed ID: 20079467
[TBL] [Abstract][Full Text] [Related]
19. Role of vitamin D3-binding protein in activation of mouse macrophages.
Yamamoto N; Naraparaju VR
J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
[TBL] [Abstract][Full Text] [Related]
20. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.
Speeckaert M; Huang G; Delanghe JR; Taes YE
Clin Chim Acta; 2006 Oct; 372(1-2):33-42. PubMed ID: 16697362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
